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Background: Cryptosporidiosis is a gastrointestinal disease affecting many people worldwide. Disease incidence is
often unknown and surveillance of human cryptosporidiosis is installed in only a handful of developed countries. A
genetic marker that mirrors disease incidence is potentially a powerful tool for monitoring the two primary human
infected species of Cryptosporidium.
Methods: We used the molecular epidemiological database with Cryptosporidium isolates from ZoopNet, which
currently contains more than 1400 records with their sampling nations, and the names of the host species from
which the isolates were obtained. Based on 296 C. hominis and 195 C. parvum GP60 sequences from human origin,
the genetic diversities of Cryptosporidium was estimated for several nations. Notified cases of human
cryptosporidiosis were collected from statistics databases for only four nations.
Results: Genetic diversities of C. hominis were estimated in 10 nations in 5 continents, and that of C. parvum of
human origin were estimated in 15 nations. Correlation with reported incidence of human cryptosporidiosis in four
nations (the Netherlands, United States, United Kingdom and Australia) was positive and significant. A linear model
for testing the relationship between the genetic diversity and incidence produced a significantly positive estimate
for the slope (P-value < 0.05).
Conclusions: The hypothesis that genetic diversity at GP60 locus mirrors notification rates of human cryptosporidiosis
was not rejected based on the data presented. Genetic diversity of C. hominis and C. parvum may therefore be an
independent and complementary measure for quantifying disease incidence, for which only a moderate number of
stool samples from each nation are sufficient data input.
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Cryptosporidium is one of the most common diarrhea-
causing parasitic genera in the world [1-3]. Human
cryptosporidiosis is a notifiable disease in several, mainly
European countries [4] where cryptosporidiosis cases are
primarily recorded in reports of incidental water and
food borne outbreaks [5].
Cryptosporidium parasites that are important for
humans are classified into the two main species,
C. hominis and C. parvum, and further into subtype* Correspondence: katsuhisa.takumi@rivm.nl
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[6, 7] that encodes a surface glycoprotein. The gene
might be under selection by host antibody response.
Global variability within and between species was inves-
tigated based on its amino-acid polymorphism [8].
Cryptosporidium is a parasite that has a sexual lifecycle,
with most of the stages of the lifecycle being haploid
while the zygote is diploid and the oocyst contains four
sporozoites that should represent two different sets of
identical recombinant genes if parental isolates are gen-
etically different. This means that sexual recombination
is likely to be common if strains from different genetic
heritages infect the same animal or person. Mallon et al.
argued that the populations of C. parvum in the UKrticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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of C. hominis are more clonal [9]. Cryptosporidium
isolates from humans and from animals in various
countries have been sequenced and compiled into a
database [10, 11]. This database, made possible by a
European consortium (ZoopNet), is a source of molecu-
lar and epidemiological information about the protozoan
infection in humans and in animals (Giardia and
Cryptosporidium). In particular, sampled countries cover
parts of the globe extending to the continents of Asia
and Africa in addition to America, Europe, and
Australia. The broad geographic range is a strong
asset of the database, if we can infer the population
risk of human cryptosporidiosis from the regional se-
quence data.
Here, we test the hypothesis that the genetic diversity
of Cryptosporidium at the GP60 locus from human iso-
lates positively correlates with the population risk. In
other words, the exposure to infectious oocysts in a hu-
man population could be indirectly measured by quanti-
fying the genetic diversities of C. hominis and C. parvum
DNA sequences, as found in human fecal samples. Each
cell division is a potential event for a novel genetic vari-
ant. Hence, a higher number of cell divisions per unit
time should drive genome to a greater diversity. The rate
of cell divisions for Cryptosporidium species that infect
humans could be quantified using an annual incidence
rate as a proxy. We refer by genetic diversity to an esti-
mate for the population size based on the coalescent
theory in molecular evolution literature [12]. A similar
approach was previously applied to Lyme disease risk in
the Netherlands [13], where it revealed a concomitant
increase in the incidence of Lyme disease in humans and
in the genetic diversity of Borrelia burgdorferi sensu lato
in ticks. It presents a precedent case validating the appli-
cation of molecular evolution approach to estimating
the extent to which humans are exposed to the infec-
tious microorganism, where no alternative approach is
possible.
For the current study, national public health statistics
and the existing Cryptosporidium sequence database are
empirical input into the molecular evolutionary analysis







Netherlands 2003 – 2005 (3) 1.8 ± 1.2 [16]
US 2006 – 2008 (3) 3.2 ± 0.9 [17]
UK 2006 – 2008 (3) 7.1 ± 1.1 [4]
Australia 2004 – 2010 (7) 12.9 ± 5.0 [18, 19]Methods
Notification rates of human cryptosporidiosis per nation
Notification rates of human cryptosporidiosis were
obtained from the literature (summarized in Table 1).
For our analysis, we required the reported notification
rates to be compatible with the sequence sampling years.
In addition, we required that the rates are comparable
among nations. This meant that a nation’s notification
rate should be expressed and reported as estimated
number of cases per 100,000 residents per year
(incidence). Countries which reported rates in other nu-
merical terms, e.g., cases per 1,000,000, were not excluded.
Data in which epidemiology of human cryptosporidiosis
was quantified in a cross-sectional study (e.g., fraction of
positive stools in a sample population) were not included
in the further analysis, due to the lack of a simple conver-
sion between study-outcomes.Cryptosporidium spp. database
A network of European public health and veterinary
institutions (ZoopNet) was established to generate and
collect molecular epidemiological data from Giardia
and Cryptosporidium isolates. The current database
(February 2013) contains more than 1400 records of
GP60 sequences, sampled countries, and host species
from which isolates were collected. Cryptosporidium
isolates of human (n = 882), animal (n = 374) or unknown
origin (n = 199) present in the ZoopNet-database [11]
were collected from European countries on a voluntary
basis. Cryptosporidium GP60 DNA sequences were also
downloaded and frequently updated from the Entrez
Nucleotide Database (GenBank) at the National Center
for Biotechnology Information and processed as de-
scribed [8]. The GP60 sequences were downloaded to-
gether with the geographical origin (country) and the
host species from which the isolate originated. Sequences
which did not originate from natural isolates were ex-
cluded. Sequences that were too short to cover regions of
variation were also excluded from further analysis. Share
of GenBank GP60 sequences in the ZoopNet database is
approximately 75 %. All molecular epidemiological data
for 296 C. hominis and 195 C. parvum sequences were
stored and analysed in Bionumerics (Version 6.6, Applied
Math, Belgium). DNA sequences and data used for this
study are available upon request.
Subtype families of the isolates were identified based
on amino acid sequence similarity. Cryptosporidium
sequences of known species and subtype families were
retrieved from GenBank using the accession numbers
AY738184 to AY738196 [7]. For each human isolate,
Smith Waterman Similarity scores were calculated on
the pair of amino acid sequences using BLOSUM62 rule
and Gap penalty of 4.
Fig. 1 Genetic diversity of two human-infective species of
Cryptosporidium. C. hominis (panel a) and C. parvum of human
origin (panel b). The horizontal axis represents the genetic diversity of
GP60 sequences per nation: a coalescent effective population size
multiplied by mutation rate per generation at GP60 locus. The
horizontal line aligned to a nation name represents the posterior
credible interval around the estimated genetic diversity. The integer
next to the right vertical axis is the number of GP60 sequences used
in the estimation
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Genetic diversity of human isolates was estimated separ-
ately for C. hominis and C. parvum. For each species,
GP60 sequences were grouped per nation and the se-
quences were aligned using the multiple alignment soft-
ware MAFFT [14]. An observed base substitution in the
alignment should have same contribution to the
estimation of genetic diversity whether it is due to point
mutation, viral infection or recombination. Subse-
quently, the alignments were analyzed per nation by
a molecular evolution approach using the software
Bayesian Evolutionary Analysis by Sampling Trees
(BEAST, version 1.8) [12]. Reconstructing phylogenetic
tree is not our primary scope. Hence, we used the default
setting in the software: Hasegawa-Kishino-Yamamoto
(HKY) model of DNA evolution and a constant mutation
rate for each site of the GP60 sequences. We ran each
simulation for one million updates and discarded 10 %
burn-in. At least two GP60 sequences from human iso-
lates per nation were necessary for this analysis, and
nations were excluded from the analysis when this condi-
tion was not met. BEAST produced a list of posterior
samples for the population size estimates based on the
coalescent theory.
Statistical analysis
Notification rates account for the two major Cryptospor-
idium species. Hence, we combined the genetic diver-
sities estimated separately for each species into one
measure. We performed all statistical computations de-
scribed in this section using the software Mathematica,
version 9 (Champaign, IL, Wolfram Research, Inc).
Overall genetic diversity was obtained by summing the
two posterior distributions from BEAST runs, weighted
according to the observed frequencies of C. hominis and
C. parvum in the total number of isolates per nation
(Fig. 1a and 1b). To calculate the weighted sum, we
applied the standard kernel-smoothing function in
Mathematica to the list of posterior samples to obtain a
continuous distribution.
The relationship between the genetic diversity and the
notification rate from the same nation was obtained by
calculating the bivariate, i.e., 2-dimensional, distribution
from the univariate distribution on genetic diversity and
the univariate distribution on annual notification rate.
The two random variables were assumed independent.
To calculate the distribution on the notification rate, we
applied the kernel-smoothing function to the list of
annual notification rates reported in national statistics.
We calculated Pearson correlation and Spearman rank,
together with their significance values based on 20 ran-
dom samples from the relationship describing the gen-
etic diversity and the notification rate. The relationship
was calculated by summing nation-specific bivariatedistributions, weighted according to the observed numbers
of Cryptosporidium sequences per nation. The numbers of
sampled sequences in each country are listed in Fig. 1.
In addition to the correlation analysis, we tested
whether the mean notification rate is proportional to the
mean genetic diversity. We applied a generalized linear
model with Gaussian response and identity link to the
set of four pairs of mean values: the genetic diversity and
the notification rate. The goodness of fit of the linear
model was assessed by the likelihood ratio test. P-values
smaller than 0.05 were considered to be significant.
Results
Genetic diversities of C. hominis were estimated for ten
nations from five continents (Fig. 1a) by a molecular
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GP60 sequences revealed that genetic diversity estimates
differed among nations. The highest genetic diversity
was estimated from 94 GP60 sequences from Australia,
whereas the lowest genetic diversity was estimated from
seven GP60 sequences from Italy. Estimates of genetic
diversities were independent of the sampling sizes, but
tend to be uncertain with smaller sampling sizes
(Fig. 1a).
Genetic diversities of C. parvum from human isolates
were estimated for 15 nations (Fig. 1b). The highest gen-
etic diversity was estimated from 35 GP60 sequences
from the UK. The lowest genetic diversity was estimated
from three GP60 sequences from India. As for C. homi-
nis, the estimates of genetic diversities were independent
of the sampling sizes, but tend to be less certain with
smaller sampling sizes (Fig. 1b).
Notification rates from public health statistics (Table 1)
varied between nations. The mean notification rate was
estimated to be 1.8 cases per 100,000 residents in the
Netherlands, 3.2 cases in the US, 7.1 cases in the UK,
and 12.9 cases in Australia (Table 1). We were unable to
collect similar epidemiological data from other nations
where the protozoan genetic diversity could be estimatedFig. 2 Distribution of Cryptosporidium genetic diversities and notification ra
diversity is colored in gray shade according to its probability density. A dar
the points at which probability density is equal to a certain value. Estimate
and Australiafrom the sequence database alone (Fig. 1a and 1b). The
lack of epidemiological data therefore reduced the
number of nations available for a correlation analysis.
Four nations (The Netherlands, USA, UK, and Australia)
met the minimal data requirement to quantify the re-
lationship between the genetic diversity and the notifica-
tion rate, that is to say, two DNA sequences per species
and two annual incidence estimates. Nonetheless, we
observed that the higher the estimated genetic diversity,
the higher the national notification rates (Fig. 2).
Pearson correlation between the Cryptosporidium gen-
etic diversity and the annual notification rates was positive
(0.73) and significant (P-value < 0.05). Spearman rank was
positive (0.8) and significant (P-value < 0.05).
An independent analysis of the datasets from the four
nations based upon a generalized linear model resulted
in a significant linear relationship (P-value < 0.05) be-
tween the estimated mean genetic diversity and the esti-
mated mean notification rate (Fig. 3).
The relationship between estimated genetic diversity
and the notification rates could be specific only to the
combination of C. hominis and C. parvum genetic di-
versities. To exclude the possibility that a significant
association with the notification rates would becometes. A pair of estimates regarding the notification rate and the genetic
ker shade indicates a higher probability density. A closed line connects
s are based on the data from four countries: The Netherlands, USA, UK,
Fig. 3 Mean and standard deviation of Cryptosporidium genetic diversities and notification rates in four nations. A cross is positioned at the
estimated mean values and displayed in the size of one standard deviation in each direction of the axes. Genetic diversities were estimated
based on C. hominis and C. parvum only originating from humans. Capital letters are abbreviations for nation names: the Netherlands (NL), the
United States (USA), the United Kingdom (UK), and Australia (AUS)
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plied the statistical analyses using the C. hominis
dataset alone. Spearman rank was positive (0.8) and
significant (P-value < 0.05). The slope of the general-
ized linear model was significantly greater than zero
(P-value < 0.05). We repeated the additional analyses
using the C. parvum dataset alone. Spearman rank
was not significant (P-value = 0.1). The slope of the
generalized linear model was not significantly differ-
ent from zero (P-value = 0.2).
Discussion
A study made a suggested observation that genetic vari-
ation at GP60 locus might be essential for the parasite’s
long-term success [15]. It is therefore meritorious to
target GP60 for analyzing genetic and epidemiological
associations of the infectious disease. In this study, we
demonstrated that genetic diversities of GP60 sequences
from human isolates correlate positively with national
notification rates of human cryptosporidiosis. The mech-
anism underlying this positive correlation would require
a careful examination of many biological, environmental,
and social factors that influence the transmission and
the epidemiology of the infection. It was beyond the
scope of this study to address this complex issue.
Nonetheless, we like to comment on some factors that
might affect the result of this study. First, some C. par-
vum from human isolates might directly originate from
one or more animal reservoirs. Extensive zoonotic trans-
mission would change the estimated genetic diversity in
either upward direction or downward direction, depend-
ing on the genetic diversity of zoonotic isolates in animalreservoirs. Hence, one might expect only a weak rela-
tionship between estimated genetic diversities with hu-
man cryptosporidiosis notification rates, when extensive
transmission from animal reservoirs would occur. A sig-
nificant and positive slope of the linear model indicated
however, that zoonotic transmission interfered little on
the relationship between the estimated genetic diversity
and the epidemiology in those countries. Second, some
infections might have been acquired abroad. Over-
represented, foreign acquired infection is expected to
level the estimated genetic diversities between nations.
Contrary to this expectation, the slope of the linear
model testing the relationship between the genetic di-
versity and incidence was positive and significant, in
the developed nations where the residents might travel
more frequently compared to those in developing
nations, indicating that the overall Cryptosporidium
genetic diversity was predominantly determined by au-
tochthonous cases. It is possible that, due to social
and environmental circumstances different from the
nations analyzed in this study, human cryptosporidi-
osis acquired from livestock animals or from abroad
alters the genetic diversity and its relationship to epi-
demiology in those nations.
In the molecular evolutionary approach that we
have adopted, genetic diversity is proportional to the
product of the mutation rate and the estimate for
population size based on the coalescent theory [12].
Thus, a relative difference in the genetic diversity of
Cryptosporidium could reflect either a relative differ-
ence in the estimates for the Cryptosporidium popu-
lation sizes between nations, or a relative difference
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likely source of variation and by eliminating the possibility,
we opt for the idea that the Cryptosporidium population
size reflects the national notification rate of human
cryptosporidiosis.
Random sampling is an assumption in the molecular
evolution approach, and selectively sampled sequences
are expected to influence the estimate on genetic diver-
sity. One might expect for example that two isolates col-
lected from an outbreak in a single site are more closely
related than e.g., two isolates collected in two distant
provinces in China. This sampling bias might change the
estimates on genetic diversity in each nation in terms of
absolute value. However, we expect such bias to influ-
ence independently the reported disease incidence in
corresponding nations, and therefore, aligning genetic
diversity and disease incidence in a number of nations
by a spurious mechanism such as sampling bias appears
unlikely.
In theory, our hypothesis could be tested using any
genetic elements, including MLST and microsatellite.
GP60 sequence is rich in repeats of tri-nucleotides
(TCA, TCG and TCT). The length of the tri-nucleotide
repeats can change by a deletion and insertion events,
and this process is not accounted for by a model of
DNA evolution by a point mutation in the molecular
evolutionary approach [12]. The duplication process
would affect the estimates for the population size
based on the coalescent theory to an unknown extent.
Resolution to detect correlation would depend on the
rate of evolutionary changes of the genetic elements,
relative to a typical time scale between one infection
to the next. Even so, the more pronounced limitations
of our study would be the following: the nations used
to validate the relationship between the genetic diver-
sity and disease notification rates is a small subset of
all nations. There is no consensus on a globally repre-
sentative group of nations and how large the group
should be.
A longitudinal study in a single nation is an additional
test case to our hypothesis regarding the population
exposure and the population risk. Seasonal incidence
and dated molecular sequences from those affected
in the same season in the same nation are empirical
input to test this hypothesis based upon independent
observations.
Conclusions
Hypothesis that Cryptosporidium genetic diversity mir-
rors the notification rates of human cryptosporidiosis
could not be rejected based on the datasets from the
four developed countries. This inference from the
molecular sequences may be an independent and
alternative approach to estimate the risk of humancryptosporidiosis where collection of the samples is an
economically suitable option.
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